BiotechTube
Kent Laboratories

Kent Laboratories

Richland, United States· Est.
kentlabs.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Kent Laboratories is a long-established, private manufacturer of high-quality polyclonal antibody-based diagnostics and reagents, operating since 1974. The company's core offerings include Radial Immunodiffusion (RID) kits and fluorescein (FITC)-conjugated antisera targeting human proteins like immunoglobulins, complement components, and acute-phase proteins, which are critical for clinical and research immunology. With an FDA-registered facility and a vertically integrated 80-acre farm for sourcing, Kent emphasizes product consistency, accuracy, and long-term customer relationships. It operates a veterinary diagnostics division (JJJ Diagnostics) under USDA oversight, representing a stable, niche player in the specialized immunoassay market.

Autoimmune DiseasesImmunodeficiencyInflammatory Diseases

Technology Platform

Polyclonal antibody production and purification for immunoassays, specializing in Radial Immunodiffusion (RID) and Fluorescein (FITC) conjugation for Direct Immunofluorescence (DIF).

Opportunities

The stable demand for specialized immunology diagnostics in both human and veterinary medicine provides a consistent market.
Leveraging its GMP/USDA credentials and reputation for quality to expand its product catalog within classical immunoassay formats or into adjacent reagent areas represents a logical growth path.
The veterinary diagnostics division (JJJ Diagnostics) is a clear avenue for expansion in the growing companion animal health sector.

Risk Factors

Primary risks include technological obsolescence, as automated platforms and newer assay methods may gradually displace traditional RID and manual immunofluorescence techniques.
The company also faces concentration risk due to its narrow focus on polyclonal antibody-based diagnostics and potential regulatory or supply chain challenges associated with its animal-based production model.

Competitive Landscape

Kent Laboratories competes in specialized segments of the immunodiagnostics market against larger, diversified reagent companies (e.g., Thermo Fisher, Agilent, Bio-Rad) and smaller niche suppliers. Its competitive advantage is rooted in deep expertise in polyclonal antibodies, a reputation for high-quality, consistent products, and long-term customer relationships, rather than in competing on price or the novelty of its technology.

More companies in Biologics / Biosimilars →More companies in United States →